findmyKOL
Clinical trialNCT00025688UnknownPhase 3Interventional

Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer

SponsorTheradexBreast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Highlands Oncology Group

    Springdale, Arkansas, United States

  • Monterey Bay Oncology

    Monterey, California, United States

  • Wilshire Oncology Medical Group, Inc.

    Pomona, California, United States

  • University of California Davis Cancer Center

    Sacramento, California, United States

  • New Britain General Hospital

    New Britain, Connecticut, United States

  • Center for Hematology and Oncology

    Boca Raton, Florida, United States

  • Cancer Research Network, Inc.

    Hollywood, Florida, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Macneal Cancer Center

    Berwyn, Illinois, United States

  • Oncology Specialists, Sc

    Park Ridge, Illinois, United States

  • Maine Center for Cancer Medicine and Blood Disorders

    Scarborough, Maine, United States

  • Maryland Hematology/oncology Associates

    Baltimore, Maryland, United States

  • St. John'S Mercy Medical Center

    St Louis, Missouri, United States

  • St. Barnabas Medical Center

    Livingston, New Jersey, United States

  • Finger Lakes Community Cancer Center

    Clifton Springs, New York, United States

  • Clinical Hematology & Oncology Service, Inc.

    Akron, Ohio, United States

  • Scranton Hematology-Oncology

    Scranton, Pennsylvania, United States

  • East Tennessee Oncology/hematology, P.C.

    Knoxville, Tennessee, United States

  • West Clinic

    Memphis, Tennessee, United States

  • Texas Cancer Care

    Fort Worth, Texas, United States

  • Oncology Consultants

    Houston, Texas, United States

  • Scott and White Clinic

    Temple, Texas, United States

  • Northern Virginia Oncology Group, P.C.

    Fairfax, Virginia, United States

  • Seattle Cancer Care Alliance

    Seattle, Washington, United States

  • Dean Medical Center

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2001
Primary completion
Completion
Last update posted
24 Jul 2008
Registered enrollment
Registry id
NCT00025688

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.